uniQure N.V. Other Nonoperating Income (Expense)
uniQure N.V. (QURE) reported Other Nonoperating Income (Expense) of $3.77 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-05-05
- uniQure N.V. other nonoperating income (expense) for the quarter ending 2026-03-31 was $3.77M.
- uniQure N.V. other nonoperating income (expense) for the quarter ending 2025-12-31 was $18.13M.
- uniQure N.V. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$7.22M.
- uniQure N.V. other nonoperating income (expense) for the quarter ending 2022-12-31 was $2.13M.
- uniQure N.V. other nonoperating income (expense) for fiscal 2025 was $10.90M.
- uniQure N.V. other nonoperating income (expense) for fiscal 2022 was $2.76M.
- uniQure N.V. other nonoperating income (expense) for fiscal 2021 was -$160.00K, a 133.13% decline from fiscal 2020.
- uniQure N.V. other nonoperating income (expense) for fiscal 2020 was $483.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-03-31 | $3.77M 10-Q · filed 2026-05-05 | $21.90M derived: sum of 2 quarters · filed 2026-05-05 | $14.67M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2025-12-31 | $18.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $10.90M derived: sum of 2 quarters · filed 2026-03-02 | $10.90M 10-K · filed 2026-03-02 | |
| 2025-09-30 | -$7.22M 10-Q · filed 2025-11-10 | -$7.22M 10-Q · filed 2025-11-10 | ||
| 2022-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.13M derived: sum of 2 quarters · filed 2025-02-27 | $2.07M derived: sum of 3 quarters · filed 2025-02-27 | $2.76M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$57.00K derived: sum of 2 quarters · filed 2023-11-07 | $635.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$57.00K 10-Q · filed 2023-08-01 | $635.00K 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | $692.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$160.00K 10-K · filed 2024-02-28 | |||
| 2020-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$1.72M derived: sum of 2 quarters · filed 2023-02-27 | -$1.53M derived: sum of 3 quarters · filed 2023-02-27 | $483.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $325.00K 10-Q · filed 2021-10-25 | $516.00K derived: sum of 2 quarters · filed 2021-10-25 | $2.53M 10-Q · filed 2021-10-25 | $862.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $191.00K 10-Q · filed 2021-07-26 | $2.21M 10-Q · filed 2021-07-26 | $537.00K derived: sum of 3 quarters · filed 2022-02-25 | $2.31M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $2.02M 10-Q · filed 2021-05-10 | $346.00K derived: sum of 2 quarters · filed 2022-02-25 | $2.12M derived: sum of 3 quarters · filed 2022-02-25 | $1.51M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $104.00K derived: sum of 2 quarters · filed 2022-02-25 | -$503.00K derived: sum of 3 quarters · filed 2022-02-25 | -$2.53M 10-K · filed 2022-02-25 |
| 2019-09-30 | $1.77M 10-Q · filed 2020-10-27 | $1.17M derived: sum of 2 quarters · filed 2020-10-27 | -$861.00K 10-Q · filed 2020-10-27 | -$323.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$607.00K 10-Q · filed 2020-07-30 | -$2.63M 10-Q · filed 2020-07-30 | -$2.10M derived: sum of 3 quarters · filed 2021-03-01 | -$1.83M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$2.03M 10-Q · filed 2020-04-29 | -$1.49M derived: sum of 2 quarters · filed 2021-03-01 | -$1.22M derived: sum of 3 quarters · filed 2021-03-01 | -$2.52M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $806.00K derived: sum of 2 quarters · filed 2021-03-01 | -$495.00K derived: sum of 3 quarters · filed 2021-03-01 | $208.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $268.00K 10-Q · filed 2019-10-28 | -$1.03M derived: sum of 2 quarters · filed 2019-10-28 | -$330.00K 10-Q · filed 2019-10-28 | -$2.79M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$1.30M 10-Q · filed 2019-07-29 | -$598.00K 10-Q · filed 2019-07-29 | -$3.06M derived: sum of 3 quarters · filed 2020-03-02 | -$3.06M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $703.00K 10-Q · filed 2019-04-29 | -$1.76M derived: sum of 2 quarters · filed 2020-03-02 | -$1.76M derived: sum of 3 quarters · filed 2020-03-02 | -$1.76M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$2.46M derived: sum of 2 quarters · filed 2020-03-02 | -$2.46M derived: sum of 3 quarters · filed 2020-03-02 | -$2.44M 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $29.00K 10-Q · filed 2018-11-06 | $113.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $29.00K 10-Q · filed 2018-08-08 | $113.00K derived: sum of 3 quarters · filed 2019-02-28 | $167.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $29.00K 10-Q · filed 2018-04-30 | $113.00K derived: sum of 2 quarters · filed 2019-02-28 | $167.00K derived: sum of 3 quarters · filed 2019-02-28 | $497.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $138.00K derived: sum of 2 quarters · filed 2019-02-28 | $468.00K derived: sum of 3 quarters · filed 2019-02-28 | $785.00K 10-K · filed 2019-02-28 |
| 2016-09-30 | $54.00K 10-Q · filed 2017-11-01 | $384.00K derived: sum of 2 quarters · filed 2017-11-01 | $701.00K 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $330.00K 10-Q · filed 2017-08-08 | $647.00K 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $317.00K 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | -$7.16M 10-K · filed 2018-03-14 | |||
| 2014-12-31 | $21.00K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |